AVTX
Avalo Therapeutics Inc
NASDAQ: AVTX · HEALTHCARE · BIOTECHNOLOGY
$13.20
+2.64% today
Updated 2026-04-29
Market cap
$317.21M
P/E ratio
—
P/S ratio
5,376.53x
EPS (TTM)
$-5.84
Dividend yield
—
52W range
$3 – $21
Volume
0.8M
Avalo Therapeutics Inc (AVTX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |